Latest news & insights
Boyds launches ‘Conversations in Drug Development’ podcast
Boyds has announced the launch of a brand-new podcast series that aims to keep the scientific and clinical community abreast of the latest advancements in cell and gene therapy and drug development.
Chris Moore discusses key considerations for US biotechs setting up gene therapy studies in Europe
In the viewpoint article: ‘Key considerations for US biotechs setting up gene therapy studies in the UK and Europe’, Chris highlights some of the important things organisations must consider before initiating their study.
The UK Innovative Devices Access Pathway (IDAP) pilot scheme now open for application
The UK has launched The Innovative Devices Access Pathway (IDAP) pilot, a new pathway to support the rapid development of innovative technologies.
Experts at Boyds share ten top tips for starting an early phase clinical trial
The clinical operations and medical affairs experts at Boyds have shared their ten top tips for how to start and promote the success of early phase clinical trials.
Ada Lovelace Day 2023: turning curiosity into a career
In this interview, Dr Karen Mullen discusses what inspired her to pursue a career in STEM, her tips for overcoming adversity, and how to encourage more women to consider careers in the industry.
Boyds’ Patrick Ginty presenting at the TOPRA Symposium
Senior Director of Regulatory Affairs Patrick Ginty will be speaking at the TOPRA Symposium, taking place in Lisbon from the 23-25 October. Patrick will be
Professor Alan Boyd welcomes the Innovative Devices Access Pathway (IDAP) pilot
Professor Alan Boyd welcomes the Innovative Devices Access Pathway (IDAP) pilot for medical devices that recently launched in the UK.
Boyds Regulatory experts join AAPS as guest speakers on Webinar
Boyds’ Regulatory experts, Dr Patrick Ginty and Dr Sabine Rühle, join AAPS as guest speakers for a Webinar “Highlighting US and European Regulatory Requirements for Gene and Cell Therapy Products”
